Cancer stem cells from human glioblastoma resemble but do not mimic original tumors after in vitro passaging in serum-free media

SUPPLEMENTARY MATERIALS Isolation and characterization of CSC-enriched cultures from human GBM
Cells derived from fresh surgical human GBM samples were isolated and cultured under the same serumfree conditions used for neural stem cells isolated from human adult brain [2] . About 55% of GBM samples (11 out of 20) rendered expandable cell cultures. Consistent with a previous work reported by Günther et al., [3] we observed that CSC-enriched cell lines cultured under these conditions showed different growing features that can be grouped into three clusters: spheres attached to the surface that eventually detached (cluster 1), spheres growing in suspension (cluster 2) and attached monolayer of cells in combination with spheres that eventually detached from the plate surface (cluster 3) (Supplementary Table S1 ). For the purpose of the present work, we randomly took one representative CSC-enriched culture from each group (Figure 2) .
To rule out the possibility that these cells were normal progenitor cells, we performed a Comparative Genomic Hibrydization (CGH) analysis on total DNA isolated from the first passage in culture. All three cell lines exhibited loss of heterogeneity (LOH) in chromosome 10 and duplication of chromosome 7, among other chromosomal alterations. All these alterations are hallmarks of glioblastoma (Supplementary Figure S1) .
The selected CSC-enriched cultures were grown under differentiation conditions, giving rise to cells expressing astrocyte, oligodendrocyte and neuron markers. We found an important number of cells coexpressing several lineage-restricted markers, which have been previously reported and regarded as another feature of brain tumor cells (Immunocytochemistry assay results for GBM18 shown as example in Supplementary Figure S2 ). Then, we studied the expression of CSC markers together with stemness and differentiation gene markers. We first designed and validated a collection of primers targeting the selected gene markers (Supplementary Table S2 ). We observed that GBM18 and GBM27 expressed CD133, SSEA1, CD44 and CD90 genes, all of them reported in the literature to label CSCs subpopulations, in addition of stemness genes also found in adult NSCs. Interestingly, we found no expression of CD133 and SSEA1, and a very low expression of Nestin in GBM38 (Supplementary Figure  S3) . Further analysis of GBM38 CGH showed a LOH at 4p15.32 and 11q21, the chromosomal locations of CD133 and SSEA1 respectively (Supplementary Table  S3 ). Finally, we observed equal expression of neuronal markers MAP-2 and βIII-Tub in all three CSC-enriched cell lines while the astrocytic marker GFAP was just expressed in GBM18 and GBM27, and oligodendrocyte markers CNPase and PDGFRα were highly expressed in GBM18 and GBM38 (Supplementary Figure S3) . Finally, using Shotgun proteomics, we studied these markers at the protein level. We observed the presence of CD44, Nestin, βIII-Tub, MAP2, and CNPase in all three CSC-enriched cultures. Additionally, we detected SOX2 and GFAP in GBM18 and GBM27 and PDGFRα in GBM18 and GBM38. The presence of GFAP and SOX2, in GBM18 and GBM27 and Nestin, in all three CSCs-enriched cultures, was also confirmed by immunocytochemistry (Supplementary Figure S4) . digested with trypsin and fractionated by reverse-phase chromatography at basic pH prior to LC-MS/MS (liquid chromatography coupled to tandem mass spectrometry) analysis in a 5600 TripleTOF system (AB SCIEX). Uninterpreted MS/MS data were searched against a human database (UniprotKB, 2013) concatenated with reversed sequences as decoy (containing 73,704 sequences, 36,852 forward sequences), using an in-house licensed Mascot v2.4 search engine. Data analysis was performed using Scaffold (v 4.4.5, Proteome Software), applying a False Discovery Rate (FDR) below 1% at the peptide level. B. GBM18. C. GBM27. D. GBM38. GFAP (red), SOX2 (green), Nestin (blue) and Nuclei (grey). Keywords: Type of marker: Classification of protein markers identified by shotgun proteomics; Uniprot ACC: accession number of the identified proteins based on Swiss-Prot database; Entry Name: the protein ID of the identified proteins based on Swiss-Prot database; Protein Name: the name of identified proteins based on Swiss-Prot database; Gene symbol: the gene name of the identified proteins based on Swiss-Prot database; Exclusive Unique Peptides: the number of different amino acid sequences, regardless of any modification, that are associated with a single protein (as defined by Scaffold software); Total Unique Peptides: number of different amino acid sequences that are associated with a specific protein, including those shared with other proteins (as defined by Scaffold software); Percentage sequence coverage: the percentage of all the amino acids in the protein sequence that were detected in the sample (as defined by Scaffold software).
